Participate in Research

Research is optional, but important for better medical cannabis. 

Since 2014, Santé Cannabis has been leading research in medical cannabis treatment.
With the help of thousands of participating patients, we’ve advanced medical cannabis knowledge,
and improved and standardized patient care.

You can help us by participating in one of our research programs. 

WHY PARTICIPATE?

It’s pretty easy!

It can have a big impact on scientific knowledge and clinical care

It’s your choice. You may withdraw from any study at any time

It does not change our standard of care

 

WHO CAN PARTICIPATE?

To participate in research at Santé Cannabis, you must:

  • Be aged 18 and over
  • Specifically agree (consent) to participate
  • Answer yourself or have a caregiver answer questionnaires in English or French.

In 2023, our Montreal site is seeking patients to participate in two clinical trials:

  1. Cannabis for cancer-related symptoms
  2. Cannabis for Agitation Symptom in dementia due to Alzheimer disease

We also run an observational study for patients at any Santé Cannabis location who are treated with medical cannabis or cannabinoid-based medications.

CONTACT US TO FIND OUT MORE 

ACTIVE STUDIES AT SANTÉ CANNABIS

SPONSORED CLINICAL TRIALS

Santé Cannabis runs clinical trials which require specific commitment from participants and can provide benefits such as access to innovative experimental treatments.

We are excited to share the launch of two clinical trials in 2023:

  • Cannabis for cancer-related symptoms (ClinicalTrials.gov Identifier: NCT03948074 or bit.ly/BC_Cancer_Center)
    • This Phase II clinical trial will evaluate the effects of different cannabis oils on symptoms related to cancer or cancer treatment. The trial is sponsored by Dr. Pippa Hawley of the BC Cancer Centre and is active in several Canadian provinces. Santé Cannabis is the only site in Quebec.
    • We are looking for volunteers with a life expectancy greater than or equal to 4 months, with at least one of the following symptoms related to cancer or cancer treatment and causing distress: nausea, pain, anxiety, or sleep disturbance
    • Duration of the study: 3 cycles of 16 days each. Participants may choose to do 1, 2 or 3 cycles for a total of 48 days.
  • Cannabis for Agitation Symptom in dementia due to Alzheimer disease (ClinicalTrials.gov Identifier: NCT05543681 or bit.ly/ICG-Pharma)
    • This phase II placebo-controlled randomized clinical trial is investigating the effects of a cannabis oil on the agitation symptom in dementia due to Alzheimer disease
    • The clinical trial is sponsored by an American pharmaceutical company IGC Pharma. Santé Cannabis is the only Canadian site to offer this study.
    • We are looking for adult participants with dementia due to Alzheimer’s disease who have moderate to severe agitation
    • Duration of the study: 42 days with 4 on-site visits to our Montreal clinic.
    • Participants will be compensated for their participation
A smiling patient in consultation with a Santé Cannabis doctor A smiling patient in consultation with a Santé Cannabis doctor A smiling patient in consultation with a Santé Cannabis doctor A smiling patient in consultation with a Santé Cannabis doctor A smiling patient in consultation with a Santé Cannabis doctor

OBSERVATIONAL STUDY

Our Santé Cannabis observational study follows patients along their treatment path. Participating only takes a few minutes and won’t require any extra appointments.

But you won’t be part of the study without your specific consent. Your choice won’t affect the care you will receive, and our team is here for your needs first and always.

Your participation can contribute to:

  • Better understanding medical cannabis treatment effectiveness
  • Clinical care protocols for new product formats such as capsules and topicals
  • Identification of medical cannabis risks, such as side effects
  • Improving treatment decisions for future medical cannabis patients
  • Informing future randomized controlled trials
  • Supporting healthcare professional training
Medical cannabis oil capsules for oral administration Medical cannabis oil capsules for oral administration Medical cannabis oil capsules for oral administration Medical cannabis oil capsules for oral administration Medical cannabis oil capsules for oral administration

 

We can’t stress this enough: research is important but participating is your choice.   

For more details about our observational study, read our Informed Consent Form, with information on data collection, risks and benefits, confidentiality, your rights and more. 

Participate in Research

Don’t worry if you cannot participate in the research.
We are here for your care as well.  

Reach out to us

Become a patient

 

We may have other opportunities for you to participate in research programs,
stay in touch with us by joining our newsletter.

Join here

OUR RESPONSIBILITY TO ADVANCE MEDICAL CANNABIS

We have a duty to push for improved knowledge about medical cannabis treatments and their effects on our patients’ symptoms – your symptoms.  

This includes study of:

  • Common cannabinoids, THC and CBD 
  • Common product formats, like dried cannabis, extracts and oral oils, sprays and capsules 
  • New cannabinoids, ex: CBN and CBG 
  • New product formats like sublingual strips, transdermal patches, creams, salves and other topical products 
  • Terpenes like myrcene, limonene, beta-caryophyllene and others 

We also share the data we collect by publishing articles and presenting at conferences.
To find out more, view our Publications page and our Blog.
 

Participation by our patients is what makes this possible and there is a place for everyone.
In fact, the diversity of our patients is what makes for better research.

All patients can support the understanding of medical cannabis by participating in our research program. 

Ready to become a Santé Cannabis patient? 

NEW PATIENTS